ライフサイエンスコーパス: Staphylococcus aureus

1 119 targets from Acinetobacter baumannii and Staphylococcus aureus.

2 We probe this strategy using Staphylococcus aureus.

3 nas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus.

4 lly, naturally and persistently colonised by Staphylococcus aureus.

5 the emergence of antibiotic-resistant (ABR) Staphylococcus aureus.

6 NF) caused by group A Streptococcus (GAS) or Staphylococcus aureus.

7 topic dermatitis are frequently colonized by Staphylococcus aureus.

8 detachment process for the bacterial strain Staphylococcus aureus.

9 ganisms on the in vivo 'essential' genome of Staphylococcus aureus.

10 are unable to complement an L27 deletion in Staphylococcus aureus.

11 stic microorganisms such as enteric rods and Staphylococcus aureus.

12 omotes interaction between P. aeruginosa and Staphylococcus aureus.

13 treptococcus, Corynebacterium, Moraxella, or Staphylococcus aureus.

14 ularly those caused by methicillin-resistant Staphylococcus aureus.

15 enicity and adaptation of the human pathogen Staphylococcus aureus.

16 ciated infections like methicillin-resistant Staphylococcus aureus.

17 PR/Cas9 antimicrobial, broadly applicable to Staphylococcus aureus.

18 nterococcus faecium and meticillin-resistant Staphylococcus aureus.

19 ts with patients with necrotizing fasciitis, Staphylococcus aureus (10 [43.5%] vs 4 [12.9%]; P = .02)

20 Aspergillus spp. (17%) and Staphylococcus aureus (10.7%) were the commonest pathoge

21 tions of those methods, were used to test 10 Staphylococcus aureus, 10 Streptococcus pneumoniae, 10 H

22 Staphylococcus aureus (12.9%) and Pseudomonas aeruginosa

23 cocci (21%, 10/48) and methicillin-sensitive Staphylococcus aureus (19%, 9/48).

24 positive bacterial pathogens was (88%), and Staphylococcus aureus (50.3%) was the predominantly isol

25 rgic reactions to the gram-positive pathogen Staphylococcus aureus, a frequent colonizer of the upper

26 the outcome of systemic infections caused by Staphylococcus aureus, a leading cause of bacterial endo

27 Staphylococcus aureus, a metabolically flexible gram-pos

28 In Staphylococcus aureus, a species-specific glyS T-box con

29 only occurred between siblings suggests that Staphylococcus aureus acquisition in our CF population o

30 g on NorA, the most important efflux pump of Staphylococcus aureus, an efflux pump inhibitors (EPIs)

31 nk between EET formation and the presence of Staphylococcus aureus, an organism frequently colonizing

32 ium-dependent antimicrobial activity against Staphylococcus aureus and Bacillus subtilis with MICs ra

33 taneous infections with Candida albicans and Staphylococcus aureus and chronic inflammatory disease a

34 ainst key Gram-positive pathogens (including Staphylococcus aureus and enterococci), a mode of action

35 hospital acquired infections: gram-positive Staphylococcus aureus and gram-negative Pseudomonas aeru

36 n sequester Ni(II) from two human pathogens, Staphylococcus aureus and Klebsiella pneumoniae, that ut

37 etry to detect the amplification of DNA from Staphylococcus aureus and Klebsiella pneumoniae, two pat

38 In the opportunistic pathogen Staphylococcus aureus and most other bacteria, hibernati

39 Staphylococcus aureus and P. jirovecii had higher densit

40 nic wounds are typically polymicrobial, with Staphylococcus aureus and Pseudomonas aeruginosa being t

41 Chronic coinfections of Staphylococcus aureus and Pseudomonas aeruginosa frequen

42 strains (Bacillus cereus, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa) and in

43 d be observed for pathogenic bacteria (e.g., Staphylococcus aureus and Pseudomonas aeruginosa).

44 2.6 log reductions of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa, respec

45 t lawn biofilms of bioluminescent strains of Staphylococcus aureus and Pseudomonas aeruginosa.

46 ia Escherichia coli, Listeria monocytogenes, Staphylococcus aureus and Salmonella enteritidis.

47 or-stimulating bacteria in the upper airway (Staphylococcus aureus and Staphylococcus epidermidis) an

48 t Escherichia coli, Mycobacterium smegmatis, Staphylococcus aureus and Staphylococcus simulans.

49 Regarding microorganisms, Staphylococcus aureus and streptococci slightly declined

50 ween CP and two solute-binding proteins that Staphylococcus aureus and Streptococcus pneumoniae, Gram

51 ture had direct bactericidal effects against Staphylococcus aureus and Streptococcus pyogenes and pro

52 ly monitor the growth of both gram-positive (Staphylococcus aureus and Streptococcus pyogenes) and gr

53 oded CRISPR/associated protein 9 (Cas9) from Staphylococcus aureus and Streptococcus pyogenes, and re

54 pecies commonly associated with PJI, namely, Staphylococcus aureus and Streptococcus pyogenes.

55 ning, we employ orthogonal Cas9 enzymes from Staphylococcus aureus and Streptococcus pyogenes.

56 gens (SAgs) are potent exotoxins secreted by Staphylococcus aureus and Streptococcus pyogenes.

57 erial pathogens, including Escherichia coli, Staphylococcus aureus and Vibrio cholera, identified a n

58 d short palindromic repeat-associated 9 from Staphylococcus aureus) and guide RNA constructs into an

59 increased susceptibility to both bacterial (Staphylococcus aureus) and viral (murine CMV) infection

60 eir ability to internalize Escherichia coli, Staphylococcus aureus, and Bacillus anthracis particles.

61 obacter baumannii, methicillin resistance in Staphylococcus aureus, and beta-lactam and co-trimoxazol

62 ebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and coagulase-negative staphyloco

63 igh-density populations of Escherichia coli, Staphylococcus aureus, and Mycobacterium smegmatis to qu

64 emophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii.

65 at suppress the growth of a common pathogen, Staphylococcus aureus, and predicted which genera were a

66 Salmonella enterica serovar Typhimurium LT2, Staphylococcus aureus, and Streptococcus bovis).

67 y RNAs (sRNA) in P. aeruginosa as well as in Staphylococcus aureus, another important human pathogen

68 Infections with Staphylococcus aureus are a continuing and growing probl

69 loferrin A (SA) and staphyloferrin B (SB) of Staphylococcus aureus are essential for iron acquisition

70 Coagulase-negative staphylococci (CoNS) and Staphylococcus aureus are part of the natural flora of h

71 eria monocytogenes and methicillin-resistant Staphylococcus aureus at concentrations between 0.05 and

72 um of activity of nafithromycin were tested: Staphylococcus aureus ATCC 25923 (disk only), S. aureus

73 Staphylococcus aureus bacteraemia is a common cause of s

74 mulates interleukin 10 (IL-10) production in Staphylococcus aureus bacteremia (SaB) animal models, bu

75 ic infection is an important complication of Staphylococcus aureus bacteremia (SAB).

76 have been shown to improve the management of Staphylococcus aureus bacteremia (SAB).

77 -adhering pathogens, such as Shiga toxin and Staphylococcus aureus bacteria.

78 monas aeruginosa, Moraxella catarrhalis, and Staphylococcus aureus, bacteria that occasionally coloni

79 ] and two extracellular (Vibrio cholerae and Staphylococcus aureus) bacterial pathogens.

80 ine, oxacillin and rifampicin) in preventing Staphylococcus aureus biofilms was investigated using Mi

81 r disparities existed in hospital-onset (HO) Staphylococcus aureus bloodstream infections (BSIs) and

82 ae after challenge with Escherichia coli and Staphylococcus aureus, but had no significant effect aft

83 e been implicated in nosocomial outbreaks of Staphylococcus aureus, but the dearth of evidence from n

84 fflux pump is involved in internalization of Staphylococcus aureus by A549 lung epithelial cells.

85 Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are the cause of a sever

86 Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) causes infections associ

87 e community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) epidemic in the United S

88 t, community-acquired, methicillin-resistant Staphylococcus aureus (CA-MRSA) with specific molecular

89 f community-associated methicillin-resistant Staphylococcus aureus(CA-MRSA) isolates have revealed a

90 Staphylococcus aureus can cause life-threatening infecti

91 Staphylococcus aureus causes very serious infections of

92 The Staphylococcus aureus cell surface contains cell wall-an

93 By contrast, the Gram-positive Staphylococcus aureus cells appeared to be protected fro

94 igate this, we tracked spacer acquisition in Staphylococcus aureus cells harbouring a type II CRISPR-

95 Gram-negative bacilli, Staphylococcus aureus, Chlamydia, Mycoplasma, and Legion

96 totypic housekeeping sortase A (SaSrtA) from Staphylococcus aureus cleaves LPXTG-containing proteins

97 Accordingly, Staphylococcus aureus clinical isolates differ substanti

98 Livestock-associated methicillin-resistant Staphylococcus aureus clonal complex 398 (LA-MRSA CC398)

99 Novel Staphylococcus aureus clones continue to emerge that cau

100 In Staphylococcus aureus, ClpP associates to the substrate

101 ed the highest efficiency when P. aeruginosa/Staphylococcus aureus co-culture RNA samples were tested

102 As far as this review, Staphylococcus aureus, Coagulase negative Staphylococci,

103 k et al. (2017) find that a commensal blocks Staphylococcus aureus colonization by producing a signal

104 Staphylococcus aureus colonization contributes to skin i

105 Staphylococcus aureus colonization levels inversely corr

106 asal polyps and asthma, show increased nasal Staphylococcus aureus colonization.

107 Staphylococcus aureus commonly colonizes the epidermis,

108 l presence, including the frequent colonizer Staphylococcus aureus, contributes to inhibition of heal

109 Staphylococcus aureus-derived serine protease-like prote

110 specific and sensitive homogeneous assay for Staphylococcus aureus detection was developed by measuri

111 Staphylococcus aureus displays a clonal population struc

112 Infection with Staphylococcus aureus does not induce long-lived protect

113 ted with a low-diversity skin microbiota and Staphylococcus aureus dominance.

114 t Gram-positive and Gram-negative pathogens (Staphylococcus aureus, Enterobacteriaceae, Pseudomonas a

115 n and the presence of IgE antibodies against Staphylococcus aureus enterotoxins (SAEs).

116 increased uptake in vitro in live bacteria (Staphylococcus aureus, Escherichia coli, and Pseudomonas

117 y in vitro uptake in representative bacteria-Staphylococcus aureus, Escherichia coli, Pseudomonas aer

118 PC190723-resistant and -dependent strains of Staphylococcus aureus exhibit severe growth and morpholo

119 Staphylococcus aureus expresses a panel of cell wall-anc

120 Staphylococcus aureus forms biofilms on indwelling medic

121 seful single-test adjunct for distinguishing Staphylococcus aureus from S. delphini and other members

122 Staphylococcus aureus from these 2 groups were introduce

123 we observed that IFN-beta can directly kill Staphylococcus aureus Further, a mutant S. aureus that i

124 We investigated de novo mutation in 1163 Staphylococcus aureus genomes from 105 infected patients

125 The Staphylococcus aureus Group II BPL which is called BirA

126 Staphylococcus aureus has previously been shown to manip

127 lular nonsiderophilic Y enterocolitica O8 or Staphylococcus aureus Hepcidin analogs may be useful for

128 Mice with chronic Staphylococcus aureus implant infections were treated by

129 ococcus was isolated in 39 of 63 (62%) eyes, Staphylococcus aureus in 7 of 63 (11%) eyes, and Strepto

130 ve Staphylococci, Pseudomonas aeruginosa and Staphylococcus aureus in keratitis; Streptococcus viridi

131 tyrosine kinase (SYK) activity and uptake of Staphylococcus aureus in microglial cell line BV-2 in a

132 terococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus (including clinical isolates of MR

133 gene-trap method and showed that healing of Staphylococcus aureus-infected skin wounds was significa

134 ature myeloid cells, expanded during chronic Staphylococcus aureus infection and promoted bacterial p

135 y to subsequent Streptococcus pneumoniae and Staphylococcus aureus infection as well as the intensity

136 The immune response to Staphylococcus aureus infection in skin involves the rec

137 unctionally contribute to protection against Staphylococcus aureus infection.

138 uenza (21 days) did not exacerbate secondary Staphylococcus aureus infection.

139 Clostridium difficile, methicillin-resistant Staphylococcus aureus infections and vancomycin-resistan

140 Multiple candidate vaccines against Staphylococcus aureus infections have failed in clinical

141 Staphylococcus aureus infections of the skin and soft ti

142 cells are the etiologic agents of recurrent Staphylococcus aureus infections.

143 promoted the association and phagocytosis of Staphylococcus aureus into macrophages.

144 Staphylococcus aureus is a highly successful human patho

145 Staphylococcus aureus is a human commensal but also has

146 Staphylococcus aureus is a leading cause of both nosocom

147 Staphylococcus aureus is a major cause of skin and soft

148 The bacterium Staphylococcus aureus is a major human pathogen for whic

149 Staphylococcus aureus is a medically important pathogen

150 The type VII secretion system (T7SS) of Staphylococcus aureus is a multiprotein complex dedicate

151 Staphylococcus aureus is a serious human pathogen with r

152 Staphylococcus aureus is an AD-associated pathogen produ

153 Staphylococcus aureus is an important opportunistic path

154 Staphylococcus aureus is an opportunistic human pathogen

155 Staphylococcus aureus is an opportunistic pathogen and v

156 Skin colonization by Staphylococcus aureus is associated with severity of ato

157 Staphylococcus aureus is highly adapted to its host and

158 Staphylococcus aureus is in competition for colonization

159 Staphylococcus aureus is the leading cause of infection

160 Staphylococcus aureus is the leading cause of skin and s

161 Staphylococcus aureus is the leading cause of skin and s

162 Staphylococcus aureus is the most common cause of skin a

163 Staphylococcus aureus is the most common infectious agen

164 r differentiating S. hyicus, S. agnetis, and Staphylococcus aureus Isolates (n = 62) were selected fr

165 elatedness and assess population dynamics of Staphylococcus aureus isolates from a cohort of CF patie

166 approximately 85% of all relaxases found in Staphylococcus aureus isolates.

167 tect mecC-mediated beta-lactam resistance in Staphylococcus aureus Kriegeskorte and colleagues report

168 Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) is an emerging problem i

169 Staphylococcus aureus, Leuconostoc mesenteroides, Bacill

170 he growth of gram-positive (Bacillus cereus, Staphylococcus aureus, Listeria monocytogenes, Geobacill

171 control practices for methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Aci

172 erminal peptide of the methicillin-resistant staphylococcus aureus (MRSA) and self-assembles to form

173 luding the "superbugs" methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant En

174 iotic activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant En

175 zed projects involving methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant en

176 the treatment of both methicillin resistant Staphylococcus aureus (MRSA) and vancomycin-resistant st

177 ere is limited data on methicillin-resistant Staphylococcus aureus (MRSA) carriage in dental clinics.

178 Methicillin-resistant Staphylococcus aureus (MRSA) caused 57% of the ISIs.

179 was targeted to reduce methicillin-resistant Staphylococcus aureus (MRSA) growth.

180 e rate of infection by methicillin-resistant Staphylococcus aureus (MRSA) has declined over the past

181 ital/ward outbreaks of methicillin-resistant Staphylococcus aureus (MRSA) identified through routine

182 e community-associated methicillin-resistant Staphylococcus aureus (MRSA) incidence in the United Sta

183 Methicillin-resistant Staphylococcus aureus (MRSA) infection is a serious thre

184 The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection was 24% and multi

185 y for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection.

186 Health care-associated methicillin-resistant Staphylococcus aureus (MRSA) infections are a burden on

187 Methicillin-resistant Staphylococcus aureus (MRSA) infections are a global pub

188 talizations related to methicillin-resistant Staphylococcus aureus (MRSA) infections between 2010 and

189 ch to the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections by demonstrating

190 Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that causes

191 Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging cause of cat

192 Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for large nu

193 Methicillin-resistant Staphylococcus aureus (MRSA) is the most common healthca

194 f community-associated methicillin-resistant Staphylococcus aureus (MRSA) is unclear.

195 ital and identified 81 methicillin-resistant Staphylococcus aureus (MRSA) isolates.

196 g epidemic lineages of methicillin-resistant Staphylococcus aureus (MRSA) over sensitive isolates (me

197 Methicillin-resistant Staphylococcus aureus (MRSA) phenotypes were predicted u

198 ce and rapid spread of methicillin-resistant Staphylococcus aureus (MRSA) poses a serious threat to p

199 Methicillin-resistant Staphylococcus aureus (MRSA) represents a major contribu

200 at increased risk for methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infect

201 ts score, preoperative methicillin-resistant Staphylococcus aureus (MRSA) status, and receipt of mupi

202 modulates virulence of methicillin-resistant Staphylococcus aureus (MRSA) via regulation of principal

203 Methicillin-resistant Staphylococcus aureus (MRSA) was first observed in 1960,

204 Meticillin-resistant Staphylococcus aureus (MRSA) was first reported in 1998

205 ococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), Listeria monocytogenes and

206 with the emergence of methicillin-resistant Staphylococcus aureus (MRSA).

207 cal bacteria including methicillin-resistant Staphylococcus aureus (MRSA).

208 and drug resistance in methicillin-resistant Staphylococcus aureus (MRSA).

209 ng to the phenotype of methicillin-resistant Staphylococcus aureus (MRSA).

210 ng domains specific to methicillin-resistant Staphylococcus aureus (MRSA).

211 iotic activity against methicillin-resistant Staphylococcus aureus (MRSA).

212 treat patients with methicillin-susceptible Staphylococcus aureus (MSSA) infections, beta-lactams ar

213 ive bacteria, namely methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant Stap

214 Perioperative decolonization of Staphylococcus aureus nasal carriers with mupirocin toge

215 Staphylococcus aureus NOS (saNOS) has previously been sh

216 ional structures of ribosomal particles from Staphylococcus aureus obtained by X-ray crystallography

217 lity of phosphate for all forms of life, how Staphylococcus aureus obtains this nutrient during infec

218 onic biofilm-associated infections caused by Staphylococcus aureus often lead to significant increase

219 Salmonella spp., Salmonella typhimurium and Staphylococcus aureus on E. coli specific antibody surfa

220 t of diseases such as tuberculosis, malaria, Staphylococcus aureus or gonorrhea has led to rapidly in

221 It is tougher to treat than most strains of Staphylococcus aureus or staph, because it is resistant

222 t affect phagocytosis of Escherichia coli or Staphylococcus aureus or their intracellular killing.

223 ignificantly higher in methicillin-resistant Staphylococcus aureus (OR, 2.80; 95% CI, 1.65-4.74) and

224 and local epidemiological investigations of Staphylococcus aureus outbreaks.

225 ificant selectivity for PrkA relative to the Staphylococcus aureus PASTA kinase Stk1.

226 Remarkably, the clinically important Staphylococcus aureus pathogenicity islands (SaPIs) use

227 Staphylococcus aureus pathogenicity islands (SaPIs), suc

228 lose sequence relationship between PBP 3 and Staphylococcus aureus PBP 2A, which is responsible for m

229 Staphylococcus aureus plays an important role in sepsis,

230 Antibiotic-resistant strains of Staphylococcus aureus pose a major threat to human healt

231 Airway-colonization by Staphylococcus aureus predisposes to the development of

232 ress response as seen, for example, with the Staphylococcus aureus PRF or sulfide oxidation and dispo

233 2017) define a pathway by which epicutaneous Staphylococcus aureus promotes skin inflammation and may

234 trated that this protease rapidly hydrolyzes Staphylococcus aureus protein A, an important S. aureus

235 To enable high-accuracy quantification of Staphylococcus aureus proteins, we have developed a glob

236 dulin alpha3 (PSMalpha3) peptide secreted by Staphylococcus aureus PSMalpha3 formed elongated fibrils

237 lar microbes, such as the bacterial pathogen Staphylococcus aureus Recruitment and activation of neut

238 do not usually develop effective immunity to Staphylococcus aureus reinfection.

239 Staphylococcus aureus remains a causative agent for morb

240 em into groups, including tandem repeats and Staphylococcus aureus repeat (STAR)-like elements.

241 ome of house dust mites (HDM) has shown that Staphylococcus aureus (S. aureus) and Escherichia coli (

242 that MCL played an anti-inflammatory role in Staphylococcus aureus (S. aureus) and methicillin-resist

243 li), Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus) and Staphylococcus epi

244 Staphylococcus aureus (S. aureus) carriage and sensitiza

245 handling and consumption in the transfer of Staphylococcus aureus (S. aureus) from livestock to cons

246 Staphylococcus aureus (S. aureus) infections are among t

247 Colonization of the skin by Staphylococcus aureus (S. aureus) is increased in atopic

248 Staphylococcus aureus (S. aureus) is one of the most com

249 Correspondingly, Staphylococcus aureus (S. aureus) isolates from lesional

250 etection of Lactobacillus species (spp.) and Staphylococcus aureus (S. aureus) using gold nanoparticl

251 wed by Streptococci (Strep) species (20.8%), Staphylococcus aureus (SA) (10.2%), other Gram-positive

252 ife-threatening infectious pathogens such as Staphylococcus aureus (SA) and Mycobacterium tuberculosi

253 purpose, we engineered the Cas9 protein from Staphylococcus aureus (SaCas9) for the imaging of endoge

254 lights on the surface of the human pathogens Staphylococcus aureus (SaEf-Tu) and Mycoplasma pneumonia

255 luate the effect of route of administration, Staphylococcus aureus skin colonization, and disease sev

256 Staphylococcus aureus skin infection is a frequent and r

257 People with diabetes are more prone to Staphylococcus aureus skin infection than healthy indivi

258 precluded primary outcome meta-analysis for Staphylococcus aureus skin or soft-tissue infections.

259 Here, we describe Staphylococcus aureus sortase A-mediated crosslinking of

260 patients presented with significantly lower Staphylococcus aureus-specific serum IgG compared to cys

261 apid and simultaneous identification (ID) of Staphylococcus aureus, Staphylococcus lugdunensis, and S

262 ed bacteria including a multi-drug resistant Staphylococcus aureus strain Y5 and ampicillin resistant

263 However, superantigen-producing Staphylococcus aureus strains are often part of the huma

264 he world, in the United States for instance, Staphylococcus aureus, Streptococcus pneumoniae and Haem

265 ata sets from six diverse bacterial species: Staphylococcus aureus, Streptococcus pneumoniae, Mycobac

266 ma-primed MCs guide activation of T cells by Staphylococcus aureus superantigen and, when preincubate

267 Staphylococcus aureus surface protein SasG promotes cell

268 y was to test the ability of WLBU2 to remove Staphylococcus aureus surgical implant biofilms.

269 2-component leukotoxin LukAB is critical for Staphylococcus aureus targeting and killing of human neu

270 Phenotypic variants of Staphylococcus aureus that display small colonies, reduc

271 tor on the surface of the bacterial pathogen Staphylococcus aureus that extracts heme from hemoglobin

272 However, for Staphylococcus aureus, the accumulation of within-host d

273 In the Gram-positive pathogen Staphylococcus aureus, the membrane-bound ATP-dependent

274 Staphylococcus aureus, the most common pathogen in bone

275 e followed 3 wk later by an i.v. exposure to Staphylococcus aureus This procedure resulted in a marke

276 d secretion in response to nigericin and the Staphylococcus aureus toxin leukocidin AB (LukAB).

277 ome-wide screen and identified the essential Staphylococcus aureus tRNA m(1)G37 methyltransferase enz

278 Finally, a modular synthesis of the Staphylococcus aureus type 5 capsular polysaccharide rep

279 Small-colony variants (SCVs) of Staphylococcus aureus typically lack a functional electr

280 al. (2017) show that the bacterial pathogen Staphylococcus aureus unexpectedly secretes and repurpos

281 Here we report the discovery of Staphylococcus aureus UppS inhibitors from an Encoded Li

282 The Gram-positive pathogen Staphylococcus aureus uses one primary resistance mechan

283 The bacterial human pathogen Staphylococcus aureus uses oxygen as a terminal electron

284 on and infection due to meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci,

285 activity against Pseudomonas aeruginosa and Staphylococcus aureus was assessed by microdilution assa

286 Among them, Staphylococcus aureus was the most predominant and was f

287 e nucleotides in the Gram-positive bacterium Staphylococcus aureus We demonstrate that the GTP synthe

288 aused by Escherichia coli, Enterococcus, and Staphylococcus aureus we observed that cocolonization wi

289 infecting the clinically relevant bacterium Staphylococcus aureus, we demonstrate for the first time

290 By examining secreted virulence factors of Staphylococcus aureus, we determine that the bacterial l

291 nella typhimurium, and methicillin-resistant Staphylococcus aureus) were successfully isolated and de

292 decision in the opportunistic human pathogen Staphylococcus aureus, which generates the phenotypic bi

293 Staphylococcus aureus, which has become the predominant

294 ns are a family of potent toxins secreted by Staphylococcus aureus, which target white blood cells pr

295 is a complication in septic infections with Staphylococcus aureus, which utilizes the released Hb as

296 Using this method 80.3 +/- 5.6% of Staphylococcus aureus with a starting concentration of

297 ssociation between Clostridium neonatale and Staphylococcus aureus with NEC (P = 0.001 and P = 0.002)

298 L and 95.4 +/- 1.0% of Methicillin-resistant Staphylococcus aureus with starting concentration of 10

299 ed honeys against Pseudomonas aeruginosa and Staphylococcus aureus, with a particular focus on two ma

300 infection, specifically Escherichia coli and Staphylococcus aureus, with differences summarized throu